Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
Fuentes-Antrás J, Martínez-Rodríguez A, Guevara-Hoyer K, López-Cade I, Lorca V, Pascual A, de Luna A, Ramírez-Ruda C, Swindell J, Flores P, Lluch A, Cescon DW, Pérez-Segura P, Ocaña A, Jones F, Moreno F, García-Barberán V, García-Sáenz JÁ. Fuentes-Antrás J, et al. Among authors: garcia barberan v. Int J Mol Sci. 2023 Jul 13;24(14):11419. doi: 10.3390/ijms241411419. Int J Mol Sci. 2023. PMID: 37511178 Free PMC article.
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors.
Pérez-Pena J, Tibor Fekete J, Páez R, Baliu-Piqué M, García-Saenz JÁ, García-Barberán V, Manzano A, Pérez-Segura P, Esparis-Ogando A, Pandiella A, Gyorffy B, Ocana A. Pérez-Pena J, et al. Front Immunol. 2019 Dec 18;10:2802. doi: 10.3389/fimmu.2019.02802. eCollection 2019. Front Immunol. 2019. PMID: 31921107 Free PMC article.
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
García-Saenz JA, Ayllón P, Laig M, Acosta-Eyzaguirre D, García-Esquinas M, Montes M, Sanz J, Barquín M, Moreno F, Garcia-Barberan V, Díaz-Rubio E, Caldes T, Romero A. García-Saenz JA, et al. BMC Cancer. 2017 Mar 22;17(1):210. doi: 10.1186/s12885-017-3185-9. BMC Cancer. 2017. PMID: 28330468 Free PMC article.
Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.
Cabezas-Camarero S, de la Orden García V, García-Barberán V, Mediero-Valeros B, Subhi-Issa AI, Llovet García P, Bando-Polaino I, Merino Menéndez S, Pérez-Segura P, Díaz-Rubio E. Cabezas-Camarero S, et al. Oncologist. 2019 Mar;24(3):293-300. doi: 10.1634/theoncologist.2018-0387. Epub 2019 Jan 2. Oncologist. 2019. PMID: 30602616 Free PMC article.
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer.
Fuentes-Antrás J, Alcaraz-Sanabria AL, Morafraile EC, Noblejas-López MDM, Galán-Moya EM, Baliu-Pique M, López-Cade I, García-Barberán V, Pérez-Segura P, Manzano A, Pandiella A, Győrffy B, Ocaña A. Fuentes-Antrás J, et al. Cancers (Basel). 2021 Feb 17;13(4):833. doi: 10.3390/cancers13040833. Cancers (Basel). 2021. PMID: 33671201 Free PMC article.
Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients.
Herrera M, Berral-González A, López-Cade I, Galindo-Pumariño C, Bueno-Fortes S, Martín-Merino M, Carrato A, Ocaña A, De La Pinta C, López-Alfonso A, Peña C, García-Barberán V, De Las Rivas J. Herrera M, et al. Mol Cancer. 2021 Apr 29;20(1):73. doi: 10.1186/s12943-021-01367-x. Mol Cancer. 2021. PMID: 33926453 Free PMC article. No abstract available.
Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer.
Noblejas-López MDM, López-Cade I, Fuentes-Antrás J, Fernández-Hinojal G, Esteban-Sánchez A, Manzano A, García-Sáenz JÁ, Pérez-Segura P, La Hoya M, Pandiella A, Győrffy B, García-Barberán V, Ocaña A. Noblejas-López MDM, et al. Among authors: garcia barberan v. Cancers (Basel). 2021 Aug 16;13(16):4118. doi: 10.3390/cancers13164118. Cancers (Basel). 2021. PMID: 34439272 Free PMC article.
Genomic mapping of copy number variations influencing immune response in breast cancer.
López-Cade I, García-Barberán V, Cabañas Morafraile E, Díaz-Tejeiro C, Saiz-Ladera C, Sanvicente A, Pérez Segura P, Pandiella A, Győrffy B, Ocaña A. López-Cade I, et al. Among authors: garcia barberan v. Front Oncol. 2022 Sep 1;12:975437. doi: 10.3389/fonc.2022.975437. eCollection 2022. Front Oncol. 2022. PMID: 36119512 Free PMC article.
39 results